HighVista Strategies’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-8,373
| Closed | -$889K | – | 119 |
|
|
2022
Q3 | $889K | Buy |
8,373
+4,606
| +122% | +$489K | 0.51% | 47 |
|
|
2022
Q2 | $367K | Buy |
+3,767
| New | +$367K | 0.22% | 83 |
|
|
2021
Q4 | – | Sell |
-13,205
| Closed | -$1.27M | – | 99 |
|
|
2021
Q3 | $1.27M | Buy |
13,205
+5,065
| +62% | +$486K | 0.84% | 32 |
|
|
2021
Q2 | $792K | Buy |
+8,140
| New | +$792K | 0.56% | 53 |
|